Posted on

2023 Week 24: Bristol-Myers Squibb (NYSE: BMY)

BMY

Portfolio Update

The FiveTwenty portfolio received $235.57 dividends in the past week. ADM, EMR, JNJ, and SON paid their quarterly dividend during the week.

Past Week Dividend$235.41
Current Quarter Dividend (Q2 2023)$1,498.34
LifeTime Dividend$11,671.92
Estimated Annual Dividend$9,527.23
Dividend Scorecard

The capital allocation for the week of 06/11/2023 to 06/17/2023 will be used to add to our position in Bristol-Myers Squibb (NYSE: BMY)

BMY – Position Update

Since our last check-in on BMY in week 12 of 2023, the company reported Q1 2023 earnings on 04/27/2023. In addition, the share price decreased from $66.53 to $64.80 during that period.

Continue reading “2023 Week 24: Bristol-Myers Squibb (NYSE: BMY)”
Posted on

2023 Week 12: Bristol-Myers Squibb (NYSE: BMY)

BMY

Portfolio Update

The FiveTwenty portfolio received $325.35 dividends in the past week. K, MMM, ORI, and PII paid their quarterly dividend during the week.

Past Week Dividend$325.35
Current Quarter Dividend (Q1 2023)$1,813.43
LifeTime Dividend$9,921.87
Estimated Annual Dividend$8,500.59
Dividend Scorecard

The capital allocation for the week of 03/19/2023 to 03/25/2023 will be used to add to our position in Bristol-Myers Squibb (NYSE: BMY).

BMY – Position Update

Since our last check-in on BMY in week 42 of 2021, the company reported FY 2021 earnings on and FY 2022 earnings on 02/02/2023. In addition the share price increased 14% from $58.36 to $66.53 during that period.

Continue reading “2023 Week 12: Bristol-Myers Squibb (NYSE: BMY)”
Posted on

2021 Week 42: Bristol-Myers Squibb (NYSE: BMY)

BMY

Portfolio Update

The FiveTwenty portfolio received no dividends in the past week.

Past Week Dividend$0
Current Quarter Dividend (Q4 2021)$246
LifeTime Dividend$1,347.33
Estimated Annual Dividend$3,083.13
Dividend Scorecard

The capital allocation for the week of 10/17/2021 to 10/23/2021 will be used to add to our position in Bristol-Myers Squibb (NYSE: BMY).

BMY – Position Update

Since our last check-in on BMY in week 35 of 2021, the company declared a quarterly dividend of $0.49 per share payable on 11/01/2021 with an ex-div date of 09/30/2021. Furthermore, BMY is scheduled to release Q3 2021 earnings on 10/27/2021. And finally, the share price has seen a significant sell during that time dropping 12.4% from $66.60 to $58.36.

Continue reading “2021 Week 42: Bristol-Myers Squibb (NYSE: BMY)”
Posted on

2021 Week 35: Bristol-Myers Squibb (NYSE: BMY)

BMY

Portfolio Update

The FiveTwenty portfolio received no dividends in the past week.

Past Week Dividend$0
Current Quarter Dividend$0
LifeTime Dividend$0
Estimated Annual Dividend$0
Dividend Scorecard

The capital allocation for the week of 08/29/2021 to 09/04/2021 will be used to add to our position in Bristol-Myers Squibb (NYSE: BMY)

BMY – Position Update

Since our last check-in on BMY in week 29 of 2021, the company reported Q2 2021 earnings on 07/28/2021. Additionally, the share price decreased 1% from $67.30 to $66.60 during the same period.

Continue reading “2021 Week 35: Bristol-Myers Squibb (NYSE: BMY)”
Posted on

2021 Week 29: Bristol-Myers Squibb (NYSE: BMY)

BMY

Portfolio Update

The FiveTwenty portfolio received no dividends in the past week.

Past Week Dividend$0
Current Quarter Dividend (Q3 2021)$36.00
LifeTime Dividend$541.34
Estimated Annual Dividend$2,152.01
Dividend Scorecard

The capital allocation for the week of 07/18/2021 to 07/24/2021 will be used to establish a position in Bristol-Myers Squibb (NYSE: BMY).

BMY – Company Profile

Bristol-Myers Squibb (BMY) is an American multinational biopharmaceutical company. The company offer products in hematology, oncology, cardiovascular, and immunology therapeutic classes. It products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, and Yervoy. Official Site | Wikipedia

Continue reading “2021 Week 29: Bristol-Myers Squibb (NYSE: BMY)”